Search results
Results From The WOW.Com Content Network
This is the list of Schedule III controlled substances in the United States as defined in section 202 of the Controlled Substances Act (21 U.S.C. § 812) and 21 CFR 1308.13. The following findings are required for substances to be placed in this schedule:
The Schedule 3 list is one of three lists. Chemicals which can be used as weapons, or used in their manufacture, but which have no, or almost no, legitimate applications as well are listed in Schedule 1, whilst Schedule 2 is used for chemicals which have legitimate small-scale applications. The use of Schedule 1, 2, or 3 chemicals as weapons is ...
The Lists are subject to the following criteria, among others: [2] [3] Schedule 1 [ 4 ] contains substances most clearly related to a chemical weapon. They have been specially developed for or have already been used as chemical weapons and there is a high risk that these substances or their precursors will be used for that purpose.
While reclassification to a Schedule III drug wouldn't make cannabis federally legal, it would put the substance at the same level as Tylenol with codeine, ketamine or testosterone. Here's what we ...
Schedule III substances include Tylenol with codeine, steroids and testosterone. By rescheduling cannabis, the drug would now be studied and researched to identify concrete medical benefits ...
Except when dispensed directly by a practitioner, other than a pharmacist, to an ultimate user, no controlled substance in Schedule III or IV, which is a prescription drug as determined under the Federal Food, Drug, and Cosmetic Act (21 USC 301 et seq.), may be dispensed without a written, electronically transmitted, or oral prescription in ...
Schedule 3/Schedule III may refer to: Third Schedule of the Constitution of India, relating to oaths and affirmations; Schedule III Controlled Substances within the ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.